Tuesday, January 22, 2019 2:55:45 AM
The Biomarkers Market was worth USD 21.67 billion in 2014 and is expected to reach approximately USD 68.93 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.72% during the forecast period.
Request a sample copy of this research: https://bit.ly/2S3UxLC
North America rules the worldwide market of biomarkers because of expanding interest of aged populace for analysis and treatment of age related illnesses. Moreover, higher rate of adoption of biomarkers technologies is likewise driving the development of biomarkers market in North America. Asia is anticipated to indicate high development rates in the following five years in worldwide biomarkers market. A portion of the elements driving the development of biomarkers market in developing markets of Asia are expanding innovative work movement in India and China, expanding number of agreement inquire about associations and low cost for carrying out clinical trials.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM